Climb Bio (CLYM) Stock: Buy, Sell, or Hold?
CLYM - Climb Bio, Inc. Common Stock
$10.94
-0.13 (-1.17%)
▼
5d:
-6.17%
30d:
-27.31%
90d:
-17.56%
WAIT
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 05, 2026
Get Alerted When CLYM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: CLYM shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: CLYM shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: CLYM is currently trading at $10.94, which is considered oversold relative to its 30-day fair value range of $12.26 to $15.68.
Technical Outlook: Technically, CLYM is in a uptrend. The price is currently testing key support at $10.73. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 45/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $27.57 (+152.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CLYM is in a uptrend. The price is currently testing key support at $10.73. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 45/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $27.57 (+152.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$12.26 -
$15.68
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 152.0% below Wall St target ($27.57)
- WARNING: Composite score 52/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$12.26 -
$15.68
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$10.73
Resistance Level
$14.39
Current Trend
Uptrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-10.91
Wall Street Target
$27.57
(+152.0%)
Share & Embed Analysis
Last updated: October 04, 2026 10:20 AM ET
Data refreshes hourly during market hours. Next update: 11:20 AM
Data refreshes hourly during market hours. Next update: 11:20 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CLYM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
22 analysts |
$294 | 67 BUY |
|
PRAX
Praxis Precision Medicin… |
STRONG BUY
19 analysts |
$644 | 67 BUY |
|
REGN
Regeneron Pharmaceutical… |
BUY
27 analysts |
$853 | 48 HOLD |
|
ACAD
ACADIA Pharmaceuticals I… |
STRONG BUY
20 analysts |
$32 | 62 BUY |
|
ELVN
Enliven Therapeutics Inc. |
STRONG BUY
13 analysts |
$74 | 66 BUY |
